TABLE 1 GLOBAL SYPHILIS TESTING MARKET, MODERATE GROWTH SCENARIO, BY GEOGRAPHY, VALUE ($MILLION), 2020-2025
TABLE 2 GLOBAL SYPHILIS TESTING MARKET, MODERATE GROWTH SCENARIO, BY GEOGRAPHY, VOLUME (MILLION), 2020-2025
TABLE 3 GLOBAL SYPHILIS TESTING MARKET, RAPID GROWTH SCENARIO, BY GEOGRAPHY, VALUE ($MILLION), 2020-2025
TABLE 4 GLOBAL SYPHILIS TESTING MARKET, RAPID GROWTH SCENARIO, BY GEOGRAPHY, VOLUME (MILLION), 2020-2025
TABLE 5 GLOBAL SYPHILIS TESTING MARKET, DIMINISHING GROWTH SCENARIO, BY GEOGRAPHY, VALUE ($MILLION), 2020-2025
TABLE 6 GLOBAL SYPHILIS TESTING MARKET, DIMINISHING GROWTH SCENARIO, BY GEOGRAPHY, VOLUME (MILLION), 2020-2025
TABLE 7 SYPHILIS PREVENTIVE SERVICES BY CDC
TABLE 8 GLOBAL SYPHILIS TESTING MARKET VALUE, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 9 GLOBAL SYPHILIS TESTING MARKET VOLUME, BY GEOGRAPHY, 2014-2020 (MILLION)
TABLE 10 GLOBAL SYPHILIS TESTING MARKET BY TYPES, VALUE ($MILLION), 2014-2020
TABLE 11 GLOBAL SYPHILIS TESTING MARKET BY TYPES, VOLUME (MILLION), 2014-2020
TABLE 12 GLOBAL SYPHILIS TESTING MARKET, BY GEOGRAPHY, 2014-2020, VALUE ($MILLION)
TABLE 13 GLOBAL SYPHILIS TESTING MARKET, BY GEOGRAPHY, 2014-2020, VOLUME (MILLION)
TABLE 14 NORTH AMERICA SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 15 NORTH AMERICA SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 16 U.S. SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 17 MEXICO SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 18 CANADA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 19 EUROPE SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 20 EUROPE SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 21 SPAIN SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 22 GREECE SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 23 BELGIUM SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 24 GERMANY SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 25 MOLDOVA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 26 UNITED KINGDOM SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 27 REST OF EUROPE SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 28 ASIA PACIFIC SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 29 ASIA PACIFIC SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 30 INDIA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 31 CHINA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 32 JAPAN SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 33 AUSTRALIA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 34 OTHERS ASIA PACIFIC SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 35 LAMEA SYPHILIS TESTING MARKET, VALUE, ($MILLION), 2014-2020
TABLE 36 LAMEA SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 37 LATIN AMERICA SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 38 LATIN AMERICA SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 39 ARGENTINA SYPHILIS TESTING MARKET , VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 40 MIDDLE EAST SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 41 AFRICA SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 42 AFRICA SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 43 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 44 ROCHE DIAGNOSTICS OPERATING SEGMENTS
TABLE 45 BIOMERIEUX COMPANY SNAPSHOT
TABLE 46 BIOMERIEUX OPERATING SEGMENTS
TABLE 47 HOLOGIC, INC. COMPANY SNAPSHOT
TABLE 48 HOLOGIC, INC. OPERATING SEGMENTS
TABLE 49 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 50 BECTON DICKINSON AND COMPANY OPERATING SEGMENTS
TABLE 51 CEPHIDE INC COMPANY SNAPSHOT
TABLE 52 CEPHEID INC. OPERATING SEGMENTS
TABLE 53 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 54 DANAHER CORPORATION OPERATING SEGMENTS
TABLE 55 AFFYMETRIX INC. COMPANY SNAPSHOT
TABLE 56 AFFYMETRIX, INC. OPERATING SEGMENTS
TABLE 57 ALERE INC. COMPANY SNAPSHOT
TABLE 58 ALERE INC. OPERATING SEGMENTS
TABLE 59 ABBOTT LABORATORIES COMPANY SNAPSHOT
TABLE 60 ABBOTT LABORATORIES OPERATING SEGMENTS
TABLE 61 DIASORIN COMPANY SNAPSHOT
TABLE 62 DIASORIN OPERATING SEGMENTS
LIST OF FIGURE
FIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020-2025)
FIG. 2 IMFPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020-2025)
FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 TOP FACTORS IMPACTING GLOBAL SYPHILIS TESTING MARKET, 2014-2020
FIG. 5 TOP INVESTMENT POCKETS OF GLOBAL SYPHILIS TESTING MARKET (2014-2020)
FIG. 6 TOP WINING STRATEGIES IN GLOBAL SYPHILIS TESTING MARKET (2011-2014)
FIG. 7 VALUE CHAIN ANALYSIS OF GLOBAL SYPHILIS TESTING MARKET
FIG. 8 SYPHILIS INCIDENCE IN MEXICO (2009-2013)
FIG. 9 SYPHILIS INCIDENCE RATE IN MEXICO (2009-2013)
FIG. 10 KEY FINANCIALS OF ROCHE DIAGNOSTICS BY GEOGRAPHY (2014)
FIG. 11 SWOT ANALYSIS OF ROCHE DIAGNOSTICS
FIG. 12 KEY FINANCIALS OF BIOMERIEUX BY APPLICATIONS (2013)
FIG. 13 KEY FINANCIALS OF BIOMERIEUX BY GEOGRAPHY (2013)
FIG. 14 SWOT ANALYSIS OF BIOMERIEUX
FIG. 15 KEY FINANCIALS OF HOLOGIC, INC. BY OPERATING SEGMENTS(2012)
FIG. 16 KEY FINANCIALS OF HOLOGIC, INC. BY GEOGRAPHY (2012)
FIG. 17 SWOT ANALYSIS OF HOLOGIC, INC.
FIG. 18 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY BY SEGMENT (2013)
FIG. 19 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY BY GEOGRAPHY (2013)
FIG. 20 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 21 KEY FINANCIALS OF CEPHEID INC. BY GEOGRAPHY(2013)
FIG. 22 KEY FINANCIALS OF CEPHEID INC. BY CLINICAL AND NON CLINICAL MARKET(2013)
FIG. 23 SWOT ANALYSIS OF CEPHEID INC.
FIG. 24 KEY FINANCIALS OF DANAHER CORPORATION BY OPERATING (SEGMENT) 2013
FIG. 25 KEY FINANCIALS OF DANAHER CORPORATION BY GEOGRAPHY (2013)
FIG. 26 SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 27 KEY FINANCIALS OF AFFYMETRIX, INC. BY OPERATING SEGMENTS (2013)
FIG. 28 KEY FINANCIALS OF AFFYMETRIX, INC. BY GEOGRAPHY (2013)
FIG. 29 SWOT ANALYSIS OF AFFYMETRIX INC.
FIG. 30 KEY FINANCIALS OF ALERE INC. BY THERAPEUTICS (2013)
FIG. 31 KEY FINANCIALS OF ALERE INC. BY GEOGRAPHY (2013)
FIG. 32 SWOT ANALYSIS OF ALERE INC.
FIG. 33 KEY FINANCIALS OF ABBOTT LABORATORIES BY OPERATING SEGMENTS (2013)
FIG. 34 SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 35 KEY FINANCIALS OF DIASORIN BY TECHNOLOGY (2013)
FIG. 36 KEY FINANCIALS OF DIASORIN BY GEOGRAPHY (2013)
FIG. 37 SWOT ANALYSIS OF DIASORIN